112 related articles for article (PubMed ID: 33459066)
1. EIF3B promotes cancer progression in pancreatic cancer.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Scand J Gastroenterol; 2021 Mar; 56(3):281-288. PubMed ID: 33459066
[TBL] [Abstract][Full Text] [Related]
2. Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
Xiang P; Sun Y; Fang Z; Yan K; Fan Y
Mamm Genome; 2020 Aug; 31(7-8):197-204. PubMed ID: 32556998
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
[TBL] [Abstract][Full Text] [Related]
4. Effects of EIF3B gene downregulation on apoptosis and proliferation of human ovarian cancer SKOV3 and HO-8910 cells.
Wang L; Ouyang L
Biomed Pharmacother; 2019 Jan; 109():831-837. PubMed ID: 30551537
[TBL] [Abstract][Full Text] [Related]
5. Eukaryotic Translation Initiation Factor 3 Subunit B Is a Promoter in the Development and Progression of Pancreatic Cancer.
Ren H; Mai G; Liu Y; Xiang R; Yang C; Su W
Front Oncol; 2021; 11():644156. PubMed ID: 33996561
[No Abstract] [Full Text] [Related]
6. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
[TBL] [Abstract][Full Text] [Related]
7. TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma.
Xu F; Zhang S; Liu Z; Gu J; Li Y; Wang L; Mao W; Zhu Q; Shou H; Ge D; Lu C
BMC Cancer; 2019 Sep; 19(1):875. PubMed ID: 31481019
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of eukaryotic translation initiation factors 3B (EIF3B) inhibits proliferation and promotes apoptosis in glioblastoma cells.
Liang H; Ding X; Zhou C; Zhang Y; Xu M; Zhang C; Xu L
Neurol Sci; 2012 Oct; 33(5):1057-62. PubMed ID: 22234522
[TBL] [Abstract][Full Text] [Related]
9. RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells.
Wang Z; Chen J; Sun J; Cui Z; Wu H
World J Surg Oncol; 2012 Jun; 10():119. PubMed ID: 22734884
[TBL] [Abstract][Full Text] [Related]
10. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
[TBL] [Abstract][Full Text] [Related]
11. Eukaryotic translation initiation factor 3 subunit B could serve as a potential prognostic predictor for breast cancer.
Song S; Liu J; Zhang M; Gao X; Sun W; Liu P; Wang Y; Li J
Bioengineered; 2022 Feb; 13(2):2762-2776. PubMed ID: 35040374
[TBL] [Abstract][Full Text] [Related]
12. Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells.
Choi YJ; Lee YS; Lee HW; Shim DM; Seo SW
Bone Joint Res; 2017 Mar; 6(3):186-193. PubMed ID: 28360085
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA RP11-284P20.2 promotes cell proliferation and invasion in hepatocellular carcinoma by recruiting EIF3b to induce c-met protein synthesis.
Fang QL; Zhou JY; Xiong Y; Xie CR; Wang FQ; Li YT; Yin ZY; Luo GH
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32100822
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of eukaryotic translation initiation factor 3b inhibited proliferation and metastasis of gastric cancer.
Ma F; Li X; Ren J; Guo R; Li Y; Liu J; Sun Y; Liu Z; Jia J; Li W
Cell Death Dis; 2019 Aug; 10(9):623. PubMed ID: 31423012
[TBL] [Abstract][Full Text] [Related]
15. eIF3b regulates the cell proliferation and apoptosis processes in chronic myelogenous leukemia cell lines via regulating the expression of C3G.
Huang L; Wei Z; Chang X; Zheng X; Yan J; Huang J; Zhang J; Sheng L
Biotechnol Lett; 2020 Jul; 42(7):1275-1286. PubMed ID: 32236758
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.
Zhao N; Guo Y; He Y; Chen Y; Xing J
J Clin Lab Anal; 2020 Aug; 34(8):e23354. PubMed ID: 32419232
[TBL] [Abstract][Full Text] [Related]
17. EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway.
Wang L; Wen X; Luan F; Fu T; Gao C; Du H; Guo T; Han J; Huangfu L; Cheng X; Ji J
Cancer Manag Res; 2019; 11():7877-7891. PubMed ID: 31686906
[TBL] [Abstract][Full Text] [Related]
18. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo.
Han X; Kuang T; Ren Y; Lu Z; Liao Q; Chen W
Exp Cell Res; 2019 Dec; 385(1):111605. PubMed ID: 31493385
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic initiation factor 3b regulates the development and progression of breast cancer.
Li Y; Zhao J; Yuan Z; Yuan D; Fang M; Xie M; Xia M
Am J Cancer Res; 2023; 13(5):2188-2200. PubMed ID: 37293180
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation.
Xu C; Shen Y; Shi Y; Zhang M; Zhou L
Cancer Cell Int; 2022 Apr; 22(1):161. PubMed ID: 35459206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]